Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - follitropin alfa, quantity: 300 iu - injection, solution - excipient ingredients: polysorbate 20; water for injections; sodium hydroxide; benzalkonium chloride; benzyl alcohol; mannitol; methionine; monobasic sodium phosphate dihydrate - 1. the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated.,2. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies.,3. ovaleap is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - follitropin alfa, quantity: 900 iu - injection, solution - excipient ingredients: polysorbate 20; benzalkonium chloride; sodium hydroxide; water for injections; benzyl alcohol; mannitol; methionine; monobasic sodium phosphate dihydrate - 1. the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated.,2. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies.,3. ovaleap is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - follitropin alfa, quantity: 450 iu - injection, solution - excipient ingredients: benzalkonium chloride; benzyl alcohol; mannitol; water for injections; methionine; polysorbate 20; sodium hydroxide; monobasic sodium phosphate dihydrate - 1. the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated.,2. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies.,3. ovaleap is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Νότια Αφρική - Αγγλικά - South African Health Products Regulatory Authority (SAHPRA)

merck (pty) ltd - injection - each vial contains urofollitropin 75 iu

Νότια Αφρική - Αγγλικά - South African Health Products Regulatory Authority (SAHPRA)

delfran (pty) ltd - injection - see ingredients - each vial contains urofollitropin 75,0 iu

Νότια Αφρική - Αγγλικά - South African Health Products Regulatory Authority (SAHPRA)

ferring (pty) ltd - injection - each vial contains urofollitropin 75,0 i.u.